Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ajog.2024.02.290 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Assessing the prevalence of antimicrobial resistance among pediatric patients at Kamuzu Central Hospital, Malawi.
J Infect Dev Ctries
August 2025
Division of Epidemiology and Biostatistics, Global Health Department, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Introduction: Severe bacterial infections cause significant disease burden in developing countries, including Malawi. The situation is compounded by the scarcity of resources, inconsistent availability of antibiotics, and increasing antimicrobial resistance (AMR).
Methodology: This was a descriptive retrospective study where we analyzed blood culture results of pediatric patients admitted to Kamuzu Central Hospital (KCH), Lilongwe, Malawi.
A Randomized, Observer-Blinded, Active-Controlled, Phase IIIb Study to Compare IV/Oral Delafloxacin Fixed-Dose Monotherapy With Best Available Treatments in a Microbiologically Enriched Population With Surgical Site Infections: The DRESS Study.
Open Forum Infect Dis
September 2025
Faculty of Medicine and Surgery, Catholic University of Sacred Heart, Rome, Italy.
Background: Surgical site infections (SSIs) are the most common skin and skin structure infections and are mostly polymicrobial, requiring hospitalization and broad-spectrum antibiotics. This clinical trial evaluated the noninferiority of delafloxacin vs best available therapy (BAT) for the treatment of superficial or deep incisional SSI following a cardiothoracic/related leg or abdominal surgical procedure.
Methods: In this randomized, observer-blinded, active-controlled, parallel-group, multicenter, phase IIIb study, patients with SSI were randomized 1:1 to receive delafloxacin 300 mg intravenous (IV)/450 mg oral (OS) or BAT IV/OS (vancomycin or linezolid for cardiothoracic SSI, piperacillin/tazobactam or tigecycline for abdominal SSI).
One health approach unravels worrying antimicrobial resistance patterns: A cross-sectional study in Kisii, Kenya.
PLoS One
September 2025
German Center for Infection Research (DZIF), partner site Tübingen, Germany.
Background: Antimicrobial resistance (AMR) is a major public health challenge, particularly in Sub-Saharan Africa, where diagnostic and surveillance capacities are limited. Enterobacterales significantly contribute to AMR, with environmental reservoirs facilitating transmission between humans, animals, and the environment.
Methods: This study investigated the prevalence and antimicrobial susceptibility of selected Enterobacterales in human, water, animal feces, and soil samples in Kenya.
Comparative Analysis of Biofilm Formation and Antibiotic Resistance in Five ESKAPE Pathogen Species from a Tertiary Hospital in Bangladesh.
Antibiotics (Basel)
August 2025
Environmental Microbiology Laboratory, Department of Microbiology, University of Dhaka, Dhaka 1000, Bangladesh.
: Four of the six ESKAPE pathogens are responsible for a majority of antimicrobial resistance (AMR)-related deaths worldwide. Identifying the pathogens that evade antibiotic treatments more efficiently than others can help diagnose pathogens requiring more attention. The study was thus designed to evaluate the biofilm and resistance properties of five ESKAPE pathogens comparatively.
View Article and Find Full Text PDFNovel ionic liquids with antibacterial and low cytotoxic properties for double-J stents.
Urolithiasis
August 2025
Department of Biophysics, Faculty of Medicine, Istanbul University, Istanbul, Türkiye, Turkey.
Infections are common postoperative complications associated with the use of medical implants such as ureteric double-J stents. However, bacterial resistance to antibiotics poses serious risks to human health. These complications highlight the need for novel antibacterial agents.
View Article and Find Full Text PDF